News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
701,367 Results
Type
Article (42887)
Company Profile (233)
Press Release (658247)
Section
Business (210942)
Career Advice (2129)
Deals (36999)
Drug Delivery (91)
Drug Development (83557)
Employer Resources (172)
FDA (16434)
Job Trends (15476)
News (357274)
Policy (34266)
Tag
Academia (2602)
Africa (798)
Allergies (40)
Alliances (51486)
Alzheimer's disease (1121)
Antibody-drug conjugate (ADC) (54)
Approvals (16372)
Arizona (167)
Artificial intelligence (60)
Asia (40398)
Australia (6382)
Bankruptcy (366)
Best Places to Work (11372)
Biosimilars (61)
C2C Services and Suppliers (80017)
California (827)
Canada (647)
Cancer (193)
Career advice (1774)
CAR-T (38)
Cell therapy (71)
China (50)
Clinical research (64972)
Collaboration (62)
Colorado (34)
COVID-19 (2545)
Cystic fibrosis (71)
Diabetes (35)
Diagnostics (5998)
Diversity, equity & inclusion (45)
Drug pricing (59)
Earnings (84858)
Employer resources (146)
Europe (86130)
Events (110896)
FDA (16479)
Florida (106)
Funding (39)
Gene therapy (61)
GLP-1 (522)
Government (4452)
Healthcare (18848)
Hotbed/Location (492387)
Idaho (55)
Illinois (201)
Indiana (108)
Infectious disease (2560)
Inflammatory bowel disease (88)
Interviews (334)
IPO (16548)
Job creations (4148)
Job search strategy (1542)
Kansas (90)
Layoffs (406)
Legal (8415)
Liver cancer (52)
Lung cancer (43)
Maine (47)
Management (55)
Manufacturing (52)
Maryland (255)
Massachusetts (456)
Medical device (13078)
Medtech (13081)
Mergers & acquisitions (20135)
Metabolic disorders (182)
Neuroscience (1206)
New Jersey (62)
New York (83)
NextGen Class of 2024 (6657)
Non-profit (4514)
North Carolina (167)
Obesity (119)
Opinion (199)
Parkinson's disease (30)
Patents (37)
Peanut (36)
Pennsylvania (55)
People (57985)
Phase I (20160)
Phase II (28556)
Phase III (21452)
Podcasts (55)
Policy (38)
Postmarket research (2663)
Preclinical (8548)
Rare diseases (93)
Real estate (6334)
Recruiting (65)
Regulatory (22157)
Reports (32)
Research institute (2370)
Resumes & cover letters (364)
South America (1173)
Startups (3765)
Texas (89)
United States (3051)
Vaccines (433)
Washington State (114)
Weight loss (120)
Date
Today (62)
Last 7 days (503)
Last 30 days (1957)
Last 365 days (39222)
2024 (22187)
2023 (40928)
2022 (52114)
2021 (56677)
2020 (55112)
2019 (47825)
2018 (36141)
2017 (33572)
2016 (33169)
2015 (39012)
2014 (32960)
2013 (28078)
2012 (30165)
2011 (30871)
2010 (28889)
701,367 Results for "erytech pharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.First Commercial Agreement for DispersinB®
Kane Biotech Inc. announces that it has entered into a worldwide license agreement with I-MED Pharma Inc. (“I-MED Pharma” or “I-MED”) for the DispersinB ® technology.
June 25, 2024
·
3 min read
Deals
Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.
Agile Therapeutics, Inc. today announced that it has entered into a definitive merger agreement (“Merger Agreement”) with Insud Pharma, S.L.
June 26, 2024
·
10 min read
Pharm Country
Mitsubishi Tanabe Pharma America, Inc. (MTPA) Stands with the ALS Community
Mitsubishi Tanabe Pharma America, Inc. is aware of recent external challenges facing the amyotrophic lateral sclerosis treatment landscape.
May 23, 2024
·
6 min read
Genetown
ERYTECH announces that the Commercial Court has rejected Akkadian’s request to postpone the vote on the merger with Pherecydes Pharma
ERYTECH Pharma, announced that the Lyon Commercial Court has rejected Akkadian’s request to postpone the vote on the merger with Pherecydes Pharma.
June 14, 2023
·
4 min read
Business
Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights
Nuvectis Pharma, Inc. reported its financial results for the first quarter 2024 and provided an update on recent business progress.
May 7, 2024
·
8 min read
Business
Zylö announces the creation and spinout of Atticus Pharma Inc.
Zylö recently effected a spinout of Atticus Pharma Inc., whose mission is to unlock the value of the Z-pod ® topical delivery platform in the pharmaceutical vertical.
April 17, 2024
·
3 min read
Business
FSD Pharma provides Corporate Update
FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions is pleased to provide the following corporate update.
June 28, 2024
·
10 min read
Pharm Country
Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference - May 16, 2024
Nuvectis Pharma, Inc. today announced that Ron Bentsur, Chairman and Chief Executive Officer, will present at the H.C. Wainwright 2nd BioConnect Investor Conference at the NASDAQ world headquarters in New York City.
May 16, 2024
·
1 min read
FSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, today announced that on April 5, 2024
April 8, 2024
·
6 min read
Pharm Country
Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Announces the Launch of LACRIFILL® Canalicular Gel, a Novel Therapy for Dry Eye.
Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., has launched LACRIFILL Canalicular Gel, a novel therapy for dry eye in the U.S. LACRIFILL Canalicular Gel is a cross-linked hyaluronic acid derivative and is FDA-cleared to temporarily block tear drainage by the occlusion of the canalicular system.
May 29, 2024
·
3 min read
1 of 70,137
Next
